| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 215-224 |
| Journal | Clinical Cancer Research |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone. / Ryan, C.J.; Rosenthal, M.; Ng, S.; Alumkal, J.; Picus, J.; Gravis, G.; Fizazi, K.; Forget, F.; Machiels, J.P.; Srinivas, S.; Zhu, M.; Tang, R.; Oliner, K.S.; Jiang, Y.Z.; Loh, E.; Dubey, S.; Gerritsen, W.R.
In: Clinical Cancer Research, Vol. 19, No. 1, 2013, p. 215-224.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
AU - Ryan, C.J.
AU - Rosenthal, M.
AU - Ng, S.
AU - Alumkal, J.
AU - Picus, J.
AU - Gravis, G.
AU - Fizazi, K.
AU - Forget, F.
AU - Machiels, J.P.
AU - Srinivas, S.
AU - Zhu, M.
AU - Tang, R.
AU - Oliner, K.S.
AU - Jiang, Y.Z.
AU - Loh, E.
AU - Dubey, S.
AU - Gerritsen, W.R.
PY - 2013
Y1 - 2013
U2 - 10.1158/1078-0432.CCR-12-2605
DO - 10.1158/1078-0432.CCR-12-2605
M3 - Article
VL - 19
SP - 215
EP - 224
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 1
ER -